{"schema_version":"secwatch.filing_event.v1","accession":"0001646972-23-000071","form_type":"8-K","ticker":"ACI","cik":"0001646972","company_name":"Albertsons Companies, Inc.","filed_at":"2023-10-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.929920+00:00","generated_at":"2026-06-09T22:39:08.932943+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Albertsons Q2 net income $267M ($0.46/sh); adj. EBITDA $977M, down from $1,049M YoY","bullets":["Identical sales +2.9%; digital sales +19% to 37.4M loyalty members.","Net sales $18.3B vs $17.9B YoY; gross margin 27.6% down 30 bps on pharmacy mix and shrink.","Adjusted net income $368M ($0.63/sh) vs $418M ($0.72/sh) YoY; COVID vaccine/test kit headwind $75M for H2.","Capital expenditures $1,084M in H1; 80 remodels, 3 new stores, digital investments.","Kroger merger on track; C&S store sale agreement signed Sep 8; spin-off no longer pursued."],"urls":{"canonical":"https://secwatch.observer/filing/0001646972-23-000071","json":"https://secwatch.observer/filing/0001646972-23-000071.json","markdown":"https://secwatch.observer/filing/0001646972-23-000071.md","text":"https://secwatch.observer/filing/0001646972-23-000071.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1646972/000164697223000071/0001646972-23-000071-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1646972/000164697223000071/aci-20231017.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T22:39:08.932943+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"fad667df9eb39fee87450d4b021e9802b66ed6a2","claim":"Albertsons Companies, Inc. reported second quarter of fiscal 2023, which ended September 9, 2023 results: revenue $18.3 billion, net income $266.9 million, or $0.46 per share, EPS $0.46 per share.","evidence_excerpt":"We continue to partially offset these headwinds with the benefits of our productivity initiatives.\" Second Quarter of Fiscal 2023 Results Net sales and other revenue was $18.3 billion during the 12 weeks ended September 9, 2023 (\"second quarter of fiscal 2023\") compared to $17.9 billion during the 12 weeks ended September 10, 2022 (\"second quarter of fiscal","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1646972/000164697223000071/0001646972-23-000071-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"second quarter of fiscal 2023, which ended September 9, 2023"},{"label":"Revenue","value":"$18.3 billion"},{"label":"Net income","value":"$266.9 million, or $0.46 per share"},{"label":"EPS","value":"$0.46 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}